The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

The Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC)
guidelines were last updated in 2007 (TASC II) and represented the collaboration of …

Background Among patients with chronic limb-threatening ischemia (CLTI) and
infrapopliteal artery disease, angioplasty has been associated with frequent reintervention …

The European Society of Vascular Medicine (ESVM) was founded in Paris in 2012 as a
confederation of already existing and emerging European societies of vascular medicine. At …

Advances in endovascular therapies during the past decade have broadened the options for
treating peripheral vascular disease percutaneously. Endovascular treatment offers a lower …

Background: Drug-eluting balloons (DEB) may reduce infrapopliteal restenosis and
reintervention rates versus percutaneous transluminal angioplasty (PTA) and improve …

Background—The 1-year restenosis rate after balloon angioplasty of long lesions in below-
the-knee arteries may be as high as 70%. Our aim was to investigate the efficacy of a …

The prevalence of peripheral artery disease (PAD) continues to increase worldwide. It is
important to identify patients with PAD because of the increased risk of myocardial infarction …

Objectives: The aim of this study was to assess the safety and effectiveness of directional
atherectomy (DA) for endovascular treatment of peripheral arterial disease (PAD) in …

Critical limb ischemia (CLI) is a clinical syndrome of ischemic pain at rest or tissue loss, such
as nonhealing ulcers or gangrene, related to peripheral artery disease. CLI has a high short …